HTA45 Assessing the Cost-Effectiveness of Lecanemab for Early Alzheimer's Disease Treatment: A Swiss Perspective
Abstract
Authors
Heinz Strässle Karin Elke Steinbach Benjamin Tschumi Juan Gomez Oliver Burn Kate Molloy David Trueman Janice Pan Kerigo Ndirangu Simon Rothwell